Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 2500
Single User License Price INR 183575
Corporate User License Price USD 7500
Corporate User License Price INR 550725
Site License Price USD 5000
Site License Price INR 367150
Request a Quote

Report Title

Anal Incontinence Global Clinical Trials Review, H1, 2015

Quote Request for License Type
License Type Price  
Single User License USD 2500
Site License USD 5000
Enterprise Wide License USD 7500
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Anal Incontinence Global Clinical Trials Review, H1, 2015


Quote Request for License Type
License Type Price  
Single User License USD 2500
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Anal Incontinence Global Clinical Trials Review, H1, 2015

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Anal Incontinence Global Clinical Trials Review, H1, 2015



Executive Summary

Anal Incontinence Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Anal Incontinence Global Clinical Trials Review, H1, 2015" provides data on the Anal Incontinence clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Anal Incontinence. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Anal Incontinence. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Introduction 5

Anal Incontinence 5

Report Guidance 5

Clinical Trials by Region 6

Clinical Trials and Average Enrollment by Country 7

Top Five Countries Contributing to Clinical Trials in Europe 9

Top Countries Contributing to Clinical Trials in North America 10

Top Countries Contributing to Clinical Trials in Middle East and Africa 11

Top Countries Contributing to Clinical Trials in Central and South America 12

Clinical Trials by G7 Countries: Proportion of Anal Incontinence to Gastrointestinal Clinical Trials 13

Clinical Trials by Phase in G7 Countries 14

Clinical Trials in G7 Countries by Trial Status 15

Clinical Trials by Phase 16

In Progress Trials by Phase 17

Clinical Trials by Trial Status 18

Clinical Trials by End Point Status 19

Unaccomplished Trials of Anal Incontinence 20

Subjects Recruited Over a Period of Time 21

Clinical Trials by Sponsor Type 22

Prominent Sponsors 23

Top Companies Participating in Anal Incontinence Therapeutics Clinical Trials 24

Prominent Drugs 25

Clinical Trial Profiles 26

Clinical Trial Overview of Top Companies 26

S.L.A. Pharma AG 26

Clinical Trial Overview of S.L.A. Pharma AG 26

RDD Pharma Ltd. 27

Clinical Trial Overview of RDD Pharma Ltd. 27

Laboratoire HRA Pharma 28

Clinical Trial Overview of Laboratoire HRA Pharma 28

Clinical Trial Overview of Top Institutes / Government 29

Centre Hospitalier Universitaire-Hopitaux de Rouen 29

Clinical Trial Overview of Centre Hospitalier Universitaire-Hopitaux de Rouen 29

Bezirkskrankenhaus Schwaz 30

Clinical Trial Overview of Bezirkskrankenhaus Schwaz 30

Dalhousie University 31

Clinical Trial Overview of Dalhousie University 31

Herlev Hospital 32

Clinical Trial Overview of Herlev Hospital 32

Pontificia Universidad Catolica de Chile 33

Clinical Trial Overview of Pontificia Universidad Catolica de Chile 33

Uppsala University Hospital 34

Clinical Trial Overview of Uppsala University Hospital 34

Five Key Clinical Profiles 35

Appendix 47

Abbreviations 47

Definitions 47

Research Methodology 48

Secondary Research 48

About GlobalData 49

Contact Us 49

Disclaimer 49

Source 49

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Anal Incontinence Therapeutics, Global, Clinical Trials by Region (%), 2015* 6

Anal Incontinence Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7

Anal Incontinence Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8

Anal Incontinence Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 9

Anal Incontinence Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 10

Proportion of Anal Incontinence to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 13

Anal Incontinence Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14

Anal Incontinence Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15

Anal Incontinence Therapeutics, Global, Clinical Trials by Phase (%), 2015* 16

Anal Incontinence Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 17

Anal Incontinence Therapeutics, Global, Clinical Trials by Trial Status, 2015* 18

Anal Incontinence Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 21

Anal Incontinence Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 22

Anal Incontinence Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 23

Anal Incontinence Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 24

Anal Incontinence Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 25

GlobalData Methodology 48

List of Tables

Anal Incontinence Therapeutics, Global, Clinical Trials by Region, 2015* 6

Anal Incontinence Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7

Anal Incontinence Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8

Anal Incontinence Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 9

Anal Incontinence Therapeutics Clinical Trials, North America, Top Countries, 2015* 10

Anal Incontinence Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 11

Anal Incontinence Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 12

Proportion of Anal Incontinence to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 13

Anal Incontinence Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14

Anal Incontinence Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15

Anal Incontinence Therapeutics, Global, Clinical Trials by Phase, 2015* 16

Anal Incontinence Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 17

Anal Incontinence Therapeutics, Global, Clinical Trials by Trial Status, 2015* 18

Anal Incontinence Therapeutics Clinical Trials, Global, by End Point Status, 2015* 19

Anal Incontinence Therapeutics, Global, Terminated Clinical Trials, 2015* 20

Anal Incontinence Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 21

Anal Incontinence Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 22

Anal Incontinence Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 23

Anal Incontinence Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 24

Anal Incontinence Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 25

Anal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by S.L.A. Pharma AG, 2015* 26

Anal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by RDD Pharma Ltd., 2015* 27

Anal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratoire HRA Pharma, 2015* 28

Anal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire-Hopitaux de Rouen, 2015* 29

Anal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by Bezirkskrankenhaus Schwaz, 2015* 30

Anal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by Dalhousie University, 2015* 31

Anal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by Herlev Hospital, 2015* 32

Anal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by Pontificia Universidad Catolica de Chile, 2015* 33

Anal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by Uppsala University Hospital, 2015* 34

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Anal Incontinence Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Anal Incontinence, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand